Dose released and absolute bioavailability of nicotine from a nicotine vapor inhaler

Clinical Pharmacology and Therapeutics

Volumn 59, Issue 4, 1996, Pages 394-400

  Molander, Lars ^a   Lunell, Erik ^a   Andersson, Sven Börje ^a   Kuylenstierna, Fredrik ^a  

^a Dept of Clin Pharmacol Pharmacia ^*

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG RELEASE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; TECHNIQUE; VAPOR;

ADMINISTRATION, INHALATION; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; NICOTINE; SMOKING;

EID: 0029877998     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90107-1     Document Type: Article

References (11)

1. Schneider NG. Nicotine therapy in smoking cessation. Pharmacokinetic considerations. Clin Pharmacokinet 1992;23:169-72.
2. Russell MAH, Jarvis MJ, Sutherland G, Feyerabend C. Nicotine replacement in smoking cessation: absorption of nicotine vapor from smoke-free cigarettes. JAMA 1987;257:3262-5.
3. Sepkovic DW, Colosimo SG, Axelrad CM, Adams JD, Haley NJ. The delivery and uptake of nicotine from an aerosol rod. Am J Public Health 1986;76: 1343-4.
4. Nemeth-Coslett R, MacBride S, Henningfield JE. Effects of inhaled nicotine vapor from smokeless cigarettes [Abstract]. In: Program and abstracts of the Ninety-fifth Annual Convention of the American Psychological Association, New York, August 28, 1987.
5. Tønnesen P, Nørregaard J, Mikkelsen K, Jørgensen S, Nilsson F. A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 1994;269:1-5.
6. Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ 1994;308:21-6.
7. McNabb ME. Chewing nicotine gum for 3 months: what happens to plasma nicotine levels. Can Med Assoc J 1984;131:589-92.
8. Rose JE. The role of upper airway stimulation in smoking. In: Pomerleau OF, Pomerleau CS, eds. Nicotine replacement: a critical evaluation. New York: Alan R Liss, 1988;95-108.
9. Newman SP, Pavia D, Morén F, Sheahan NF, Clarke SW. Deposition of pressurised aerosols in the human respiratory tract. Thorax 1981;36:52-5.
10. 11C-nicotine vapor in the human airway as visualized by positron emission tomography. CLIN PHARMACOL THER 1995;57:309-17.
11. Lunell E, Molander L, Leischow SJ, Fagerström KO. The effect of nicotine vapour inhalation on the relief of tobacco withdrawal symptoms. Eur J Clin Pharmacol 1995;48:235-40.